• PFHxS Disrupts Lipid Homeostasis via PPARα in Zebrafish Larv

  2026-06-13

  This study demonstrates that environmentally relevant levels of perfluorohexanesulfonic acid (PFHxS) disrupt lipid homeostasis in zebrafish larvae by activating PPARα. Integrated lipidomic and transcriptomic analyses reveal that pharmacological inhibition of PPARα can rescue specific metabolic disturbances, providing a mechanistic model for metabolic disease research.

• Optimizing Bioluminescence Assays with D-Luciferin Sodium Sa

  2026-06-12

  This article explores real-world laboratory scenarios where D-Luciferin sodium salt (SKU B8311) from APExBIO advances cell viability and metabolism assays, with an emphasis on reproducibility, sensitivity, and workflow efficiency. Drawing on current literature, including recent CAR-macrophage research, it delivers actionable insights for biomedical researchers seeking robust, quantitative bioluminescence imaging.

• VER 155008: HSP 70 Inhibitor Workflows for Cancer and Viral

  2026-06-12

  VER 155008, a potent adenosine-derived HSP 70 inhibitor, enables researchers to dissect heat shock protein signaling in cancer, apoptosis, and viral entry assays. Explore optimized protocols, troubleshooting tips, and the translational value of new host factor insights for cross-domain applications.

• Digoxin: Na+/K+ ATPase Pump Inhibitor in Cardiac & Antiviral

  2026-06-11

  Digoxin stands out as a high-purity Na+/K+ ATPase pump inhibitor, powering both cardiac contractility studies and innovative antiviral workflows. Its dual-domain effectiveness is backed by robust data and reproducible protocols, making it an essential tool for researchers tackling heart failure, arrhythmias, and chikungunya virus inhibition.

• Protease Inhibitor Cocktail (EDTA-Free, 100X in DMSO): Techn

  2026-06-11

  The Protease Inhibitor Cocktail (EDTA-Free, 100X in DMSO) prevents endogenous protease-mediated protein degradation during extraction and sample prep, without interfering with workflows that require intact divalent cations. It is not appropriate for protocols where EDTA-mediated metalloprotease inhibition is required or where DMSO is incompatible with downstream applications.

• PBS Liposomes: Elevating Macrophage Controls in Translationa

  2026-06-10

  This thought-leadership article unpacks the mechanistic and strategic value of PBS Liposomes as a gold-standard control in macrophage depletion studies. By integrating recent structural insights from TRPM3 research, we explore the interplay between immune modulation, pain pathways, and neurodevelopmental disorders. The article delivers both actionable protocol guidance and a forward-looking perspective for translational researchers seeking robust, reproducible in vivo models.

• Phytol Applications: RXR Signaling and Lyotropic Nanomateria

  2026-06-10

  Phytol (trans-Phytol) empowers precise modulation of retinoid X receptor signaling and enables new workflows in nanostructured polymer materials. This article connects mechanistic insight with actionable protocol guidance, troubleshooting tips, and strategic advances from the latest lyotropic phase research.

• MCC950 Sodium in NLRP3 Inflammasome Research: Applied Protoc

  2026-06-09

  MCC950 sodium (CRID3 sodium salt) empowers researchers to dissect NLRP3-driven inflammation with unparalleled selectivity and potency. This guide translates breakthrough evidence into actionable workflows, troubleshooting, and advanced use-cases—enabling rapid progress in inflammatory and autoimmune disease research.

• Pharmacokinetics of CSBTA in MASH: Transporter and Enzyme In

  2026-06-09

  This study provides an integrated pharmacokinetic analysis of Corydalis saxicola Bunting total alkaloids (CSBTA) in a mouse model of metabolic dysfunction-associated steatohepatitis (MASH). By dissecting the influence of disease status and dosing regimen on the systemic and hepatic disposition of major alkaloids, the research highlights transporter- and enzyme-mediated variability relevant for rational dosage design.

• KN-62: Precision Modulation of CaMKII and Calcium Channel Cr

  2026-06-08

  Explore how KN-62, 1-[N,O-bis-(5-isoquinolinesulphonyl)-N-methyl-L-tyrosy]-4-phenylpiperazine, enables advanced dissection of CaMKII inhibition, calcium channel selectivity, and metabolic regulation. This article uniquely bridges kinase inhibition with calcium channel pharmacology to inform robust experimental design.

• PF-562271 HCl: Redefining FAK/Pyk2 Inhibition for Translatio

  2026-06-08

  This thought-leadership article explores the mechanistic underpinnings and strategic advantages of deploying PF-562271 HCl as a highly selective FAK/Pyk2 inhibitor in the context of translational oncology. By bridging recent immune-oncology findings with focal adhesion kinase pathway interrogation, we provide actionable guidance for researchers aiming to overcome resistance and enhance therapeutic synergy, highlighting protocol best practices and future outlook.

• Lypressin Acetate (SKU N2888): Reliable Solutions for Cell A

  2026-06-07

  Lypressin acetate (SKU N2888) offers reproducible, quantitative activity in cell viability, vasopressor, and cytotoxicity assays, addressing common pain points in laboratory workflows. This article analyzes real-world experimental scenarios and provides evidence-based recommendations for researchers seeking robust and validated results. Read on for protocol tips, data-backed product comparisons, and practical best practices supported by peer-reviewed literature.

• AMPK–SQSTM1 Feedback Loop Drives Dual Antioxidant Activation

  2026-06-06

  The reference study uncovers a double-positive feedback loop between AMPK and SQSTM1/p62 that enables synergistic activation of AMPK and NFE2L2/NRF2, enhancing antioxidant defense under metabolic stress in cancer cells. These findings clarify the molecular adaptations underlying co-occurring STK11 and KEAP1 mutations in non-small cell lung cancer and inform targeted strategies for tumor resilience.

• Tetrazolium (chloride) in Ischemic Tissue Redox Mapping

  2026-06-05

  Explore the advanced use of Tetrazolium (chloride) as a mitochondrial redox indicator in ischemic tissue research. This article provides an in-depth analysis of assay mechanisms, protocol parameters, and translational insights, uniquely connecting biochemical principles to practical applications.

• Substance P in Pain and Inflammation Research: Applied Workf

  2026-06-05

  Substance P from APExBIO empowers researchers to dissect neurokinin pathways in pain, inflammation, and immune response. This guide blends experimental protocols, troubleshooting insights, and the latest spectral analytics for robust, reproducible results in CNS neurotransmitter studies.

14888 records 1/993 page Next 12345 下5页 Last page